荧光增白剂Tinopal LPW对蜀柏毒蛾核型多角体病毒增效作用研究

用1%TinopalLPW荧光增白剂作为蜀柏毒蛾核型多角体病毒增效剂对蜀柏毒蛾2龄幼虫进行室内毒力测定,结果表明1%TinonalLPW对ParocneriaorientaNPV有较强的增效作用。使用3.6×1011PIB/hm2 1%TinopalLPW、1.8×1011PIB/hm2 1%TinopalLPW、9.0×1010PIB/hm2 1%TinopalLPW和3.6×1011PIB/hm2、1.8×1011PIB/hm2、9.0×1010PIB/hm26种处理对林间越冬代2-3龄幼虫进行超低容量喷雾防治,结果表明除9.0×1010PIB/hm2 1%TinopalLPW表现出显著的增效作用外,其余剂量有增效作用但不显著。     

蜀柏毒蛾生物学特性及防治

1990～1991年,作者在四川平昌县对蜀柏毒蛾生物学特性及防治进行了调查研究。结果如下：蜀柏毒蛾在四川1年发生2代,以幼虫越冬;常年以越冬代的5、6龄幼虫危害较重,危害盛期从5月上旬至6月上旬,林间高温干旱气候和天敌种类及数量的锐减是导致蜀柏毒蛾猖獗的主要因素;提出以科学营林增加灭敌种类和数量的营林防治和生物防治为主的综合防治措施。     

荧光增白剂Tinopal LPW对蜀柏毒蛾核型多角体病毒增效作用研究

用1%TinopalLPW荧光增白剂作为蜀柏毒蛾核型多角体病毒增效剂对蜀柏毒蛾2龄幼虫进行室内毒力测定,结果表明1%Tinonal LPW对Parocneria orienta NPV有较强的增效作用.使用3.6×1011PIB/hm2+1%TinopalLPW、1.8×1011PIB/hm2+ 1%TinopalLPW、9.0×1010PIB/hm2+1%TinopalLPW和3.6×1011PIB/hm2、1.8×1011PIB/hm2、9.0×1010PIB/hm26种处理对林间越冬代2-3龄幼虫进行超低容量喷雾防治,结果表明除9.0×1010PIB /hm2+1%TinopalLPW 表现出显著的增效作用外,其余剂量有增效作用但不显著.     

蜀柏毒蛾核型多角体病毒基因文库的构建及几丁质酶基因的定位

蜀柏毒蛾 (ＰａｒｏｃｎｅｒｉａｏｒｉｅｎｔａＣｈａｏ)是柏木、桧柏、干头柏等柏科树种的重要食叶害虫[1] ,到目前为止仅存在于我国。蜀柏毒蛾核型多角体病毒(Ｐａｒｏｃｎｅｒｉａｏｒｉｅｎｔａｎｕｃｌｅａｒｐｏｌｙｈｅｄｒｏｖｉｒｕｓ ,ＰａｏｒＮＰＶ) [2 ]于 1991年被分离 ,该病毒对蜀柏毒蛾幼虫具有较强毒力 ,已作为一种新型的生物农药初步应用于柏木林区害虫的防治上[3] 。对这种病毒已进行了一些研究 ,包括生物活性测定 ,形态结构 ,理化特性 ,限制性内切酶分析[4 ,5] 。为了进一步研究其分子生物学特性 ,开发我国这种特有的…     

蜀柏毒蛾核型多角体病毒基因文库的构建及几丁质酶基因的定位

蜀柏毒蛾(Parocneria orienta Chao)是柏木、桧柏、干头柏等柏科树种的重要食叶害虫[1],到目前为止仅存在于我国.蜀柏毒蛾核型多角体病毒(Parocneria orienta nuclear polyhedrovirus,PaorNPV)[2]于1991年被分离,该病毒对蜀柏毒蛾幼虫具有较强毒力,已作为一种新型的生物农药初步应用于柏木林区害虫的防治上[3].对这种病毒已进行了一些研究,包括生物活性测定,形态结构,理化特性,限制性内切酶分析[4,5].为了进一步研究其分子生物学特性,开发我国这种特有的病毒资源,我们构建了部分PaorNPV基因组DNA片段的基因文库,同时以中国棉铃虫单粒包埋核型多角体病毒(HearSNPV)几丁质酶基因作探针,对PaorNPV几丁质酶基因进行了定位,结果报道如下.     

柏毒蛾属一新种

本新种在我国四川省严重为害柏树,当地群众称它为柏毛虫。据报道早在八十年前就曾发生过柏毛虫的为害,历年来又连续猖獗。1956年四川省林业厅经营科对柏毛虫进行了较大面积的有效防治,但学名一直没有解决。经研究柏毛虫是毒蛾科(Lymantriidae)柏毒蛾属(Parocneria)一新种,今命名为蜀柏毒蛾Parocneria orienta。     

蜀柏毒蛾生殖行为及性信息素产生与释放节律

为了探索蜀柏毒蛾Parocneria orienta Chao性信息素产生和释放规律, 为利用性信息素监测和防治蜀柏毒蛾奠定基础, 本研究在野外及室内温度22±1℃、 相对湿度75%~80%、 光周期14L∶10D条件下观察研究了蜀柏毒蛾成虫的羽化、 求偶、 交尾、 产卵行为, 触角电位反应测定处女雌蛾性信息素产生与释放的时辰节律。结果表明： 蜀柏毒蛾羽化行为全天可见, 主要集中在1:00-5:00, 占总羽化量的44.94%, 7:30-11:00进行婚飞和交尾, 交尾高峰期出现在8:30左右, 交配时间少则2 h, 多则8 h, 求偶、 交配均发生在光期。随着日龄的增加, 召唤时间前移并且延长, 1日龄的处女雌蛾交尾时间较短; 雌蛾羽化当天就可交尾, 2日龄雌蛾交尾率最高, 达36.67%。雌蛾分多处产卵, 雌蛾一生最高产卵量达402粒, 最低产卵量为78粒。羽化当天的雌蛾体内性信息素含量较低, 第2天最高, 以后逐日下降; 2日龄蜀柏毒蛾处女雌蛾性信息素的产生量从7:00起逐渐增加, 8:30-9:30时最高, 9:30后逐渐减小。雄蛾对处女雌蛾腺体提取物的触角电位反应在8:30-9:00最强, 说明8:30-9:00是雌蛾产生和释放性信息素的高峰期。蜀柏毒蛾的羽化、 求偶、 交尾及性信息素的产生与释放存在一定的时辰节律, 野外处女雌蛾诱蛾试验证实了性信息素释放与交配行为在时辰节律上的一致性。     

蜀柏毒蛾核型多角体病毒的分离鉴定

本文报道了新分离的一株核型多角体病毒:蜀柏毒蛾核型多角体病毒(Paroceneria orient Nuclear Polyhedrosis Virus)。其多角体为四边形、五边形、大小在1.06—2.42μm。病毒粒子杆状,大小为385×55nm。室内感染蜀柏毒蛾幼虫其死亡率达9S％具较强的毒力。     

柏毒蛾核型多角体病毒的分离鉴定

柏毒蛾核型多角体病毒的分离鉴定李崇荣,彭辉银,周显明,陈新文,谢天恩（贵州省铜仁地区林科所,铜仁５５４３００）（中国科学院武汉病毒研究所,武汉４３００７１）（贵州省林业科学研究院,贵阳５５００１１）关键词柏毒蛾,核型多角体病毒柏毒蛾（Ｐａｒｏｃｅｎｅ...     

蜀柏毒蛾核型多角体病毒结构多肽及基因组酶切分析

对蜀柏毒蛾核型多角体病毒(Parocneria orienta Nuclear polyhedrovirus,简称PaorNPV)形态结构、结构多肽、限制性内切酶图谱等特性进行了研究.采用不连续系统垂直板SDS-PAGE分析了PaorNPV的多角体蛋白、病毒粒子结构多肽.应用5种限制性内切酶对PaorNPV基因组DNA进行了酶切分析.结果表明:经热处理的多角体蛋白仅有一条带,分子量为31.5 kD,不经热处理的多角体蛋白有三条带,分子量分别为31.5 kD、29.1 kD、28.6 kD;病毒粒子包含有25种结构多肽,分子量范围在17.6-114.6 kD之间.PaorNPV DNA经BamH I.EcoR I、HindⅢ、Pst I和Xho I酶切分别产生9、12、12、12和14条片段.基因组大小平均为124.6 kb.     

Structural analysis of UBL5, a novel ubiquitin-like modifier

UBL5 is a widely expressed human protein that is strongly conserved across phylogeny. Orthologs of UBL5 occur in every eukaryotic genome characterized to date. The yeast ortholog of UBL5, HUB1, was reported to be a ubiquitin-like protein modifier important for modulation of protein function. However, unlike ubiquitin and all other ubiquitin-like modifiers, UBL5 and its yeast ortholog HUB1 both contain a C-terminal di-tyrosine motif followed by a single variable residue instead of the characteristic di-glycine found in all other ubiquitin-like modifiers. Here we describe the three-dimensional structure of UBL5 determined by NMR. The overall structure of the protein was found to be very similar to ubiquitin despite the low approximately 25% residue similarity. The signature C-terminal di-tyrosine residues in UBL5 are involved in the final beta sheet of the protein. This is very different to the di-glycine motif found in ubiquitin, which extends beyond the final beta sheet. In addition, we have confirmed an earlier report of an interaction between UBL5 and the cyclin-like kinase, CLK4, which we have determined is specific and does not extend to other cyclin-like kinase family members.     

Regulation of double-strand break-induced mammalian homologous recombination by UBL1, a RAD51-interacting protein

Mammalian RAD51 protein plays essential roles in DNA homologous recombination, DNA repair and cell proliferation. RAD51 activities are regulated by its associated proteins. It was previously reported that a ubiquitin-like protein, UBL1, associates with RAD51 in the yeast two-hybrid system. One function of UBL1 is to covalently conjugate with target proteins and thus modify their function. In the present study we found that non-conjugated UBL1 forms a complex with RAD51 and RAD52 proteins in human cells. Overexpression of UBL1 down-regulates DNA double-strand break-induced homologous recombination in CHO cells and reduces cellular resistance to ionizing radiation in HT1080 cells. With or without overexpressed UBL1, most homologous recombination products arise by gene conversion. However, overexpression of UBL1 reduces the fraction of bidirectional gene conversion tracts. Overexpression of a mutant UBL1 that is incapable of being conjugated retains the ability to inhibit homologous recombination. These results suggest a regulatory role for UBL1 in homologous recombination.     

Interaction of NUB1 with the proteasome subunit S5a

NUB1 interacts with a ubiquitin-like protein NEDD8 to target the NEDD8 monomer and neddylated proteins to the proteasome for degradation. Therefore, NUB1 is thought to be a potent downregulator of NEDD8 conjugation system. Since NUB1 possesses a UBL domain, which was previously shown to be an S5a-interacting motif in RAD23/HHR23, we initially hypothesized that NUB1 interacts with the S5a subunit of the proteasome through its UBL domain. To examine this, we performed an in vitro GST pull-down assay and a yeast two-hybrid assay. Unexpectedly, our studies revealed that NUB1 directly interacts with the S5a subunit through its C-terminal region between amino acid residues 536 and 584, not through its UBL domain. Although the UBL domain was not an S5a-interacting motif in NUB1, our further studies revealed that the UBL domain is required for the function of NUB1.     

Interaction between RING1 (R1) and the Ubiquitin-like (UBL) Domains Is Critical for the Regulation of Parkin Activity

Parkin is an E3 ligase that contains a ubiquitin-like (UBL) domain in the N terminus and an R1-in-between-ring-RING2 motif in the C terminus. We showed that the UBL domain specifically interacts with the R1 domain and negatively regulates Parkin E3 ligase activity, Parkin-dependent mitophagy, and Parkin translocation to the mitochondria. The binding between the UBL domain and the R1 domain was suppressed by carbonyl cyanide m-chlorophenyl hydrazone treatment or by expression of PTEN-induced putative kinase 1 (PINK1), an upstream kinase that phosphorylates Parkin at the Ser-65 residue of the UBL domain. Moreover, we demonstrated that phosphorylation of the UBL domain at Ser-65 prevents its binding to the R1 domain and promotes Parkin activities. We further showed that mitochondrial translocation of Parkin, which depends on phosphorylation at Ser-65, and interaction between the R1 domain and a mitochondrial outer membrane protein, VDAC1, are suppressed by binding of the UBL domain to the R1 domain. Interestingly, Parkin with missense mutations associated with Parkinson disease (PD) in the UBL domain, such as K27N, R33Q, and A46P, did not translocate to the mitochondria and induce E3 ligase activity by m-chlorophenyl hydrazone treatment, which correlated with the interaction between the R1 domain and the UBL domain with those PD mutations. These findings provide a molecular mechanism of how Parkin recruitment to the mitochondria and Parkin activation as an E3 ubiquitin ligase are regulated by PINK1 and explain the previously unknown mechanism of how Parkin mutations in the UBL domain cause PD pathogenesis.     

Structures of Atg7-Atg3 and Atg7-Atg10 reveal noncanonical mechanisms of E2 recruitment by the autophagy E1

Central to most forms of autophagy are two ubiquitin-like proteins (UBLs), Atg8 and Atg12, which play important roles in autophagosome biogenesis, substrate recruitment to autophagosomes, and other aspects of autophagy. Typically, UBLs are activated by an E1 enzyme that (1) catalyzes adenylation of the UBL C terminus, (2) transiently covalently captures the UBL through a reactive thioester bond between the E1 active site cysteine and the UBL C terminus, and (3) promotes transfer of the UBL C terminus to the catalytic cysteine of an E2 conjugating enzyme. The E2, and often an E3 ligase enzyme, catalyzes attachment of the UBL C terminus to a primary amine group on a substrate. Here, we summarize our recent work reporting the structural and mechanistic basis for E1-E2 protein interactions in autophagy.     

Structural dissection of a gating mechanism preventing misactivation of ubiquitin by NEDD8's E1

Post-translational covalent modification by ubiquitin and ubiquitin-like proteins (UBLs) is a major eukaryotic mechanism for regulating protein function. In general, each UBL has its own E1 that serves as the entry point for a cascade. The E1 first binds the UBL and catalyzes adenylation of the UBL's C-terminus, prior to promoting UBL transfer to a downstream E2. Ubiquitin's Arg 72, which corresponds to Ala72 in the UBL NEDD8, is a key E1 selectivity determinant: swapping ubiquitin and NEDD8 residue 72 identity was shown previously to swap their E1 specificity. Correspondingly, Arg190 in the UBA3 subunit of NEDD8's heterodimeric E1 (the APPBP1-UBA3 complex), which corresponds to a Gln in ubiquitin's E1 UBA1, is a key UBL selectivity determinant. Here, we dissect this specificity with biochemical and X-ray crystallographic analysis of APPBP1-UBA3-NEDD8 complexes in which NEDD8's residue 72 and UBA3's residue 190 are substituted with different combinations of Ala, Arg, or Gln. APPBP1-UBA3's preference for NEDD8's Ala72 appears to be indirect, due to proper positioning of UBA3's Arg190. By contrast, our data are consistent with direct positive interactions between ubiquitin's Arg72 and an E1's Gln. However, APPBP1-UBA3's failure to interact with a UBL having Arg72 is not due to a lack of this favorable interaction, but rather arises from UBA3's Arg190 acting as a negative gate. Thus, parallel residues from different UBL pathways can utilize distinct mechanisms to dictate interaction selectivity, and specificity can be amplified by barriers that prevent binding to components of different conjugation cascades.     

UBL5 is essential for pre‐mRNA splicing and sister chromatid cohesion in human cells

UBL5 is an atypical ubiquitin‐like protein, whose function in metazoans remains largely unexplored. We show that UBL5 is required for sister chromatid cohesion maintenance in human cells. UBL5 primarily associates with spliceosomal proteins, and UBL5 depletion decreases pre‐mRNA splicing efficiency, leading to globally enhanced intron retention. Defective sister chromatid cohesion is a general consequence of dysfunctional pre‐mRNA splicing, resulting from the selective downregulation of the cohesion protection factor Sororin. As the UBL5 yeast orthologue, Hub1, also promotes spliceosome functions, our results show that UBL5 plays an evolutionary conserved role in pre‐mRNA splicing, the integrity of which is essential for the fidelity of chromosome segregation.     

Previously uncharacterized interactions between the folded and intrinsically disordered domains impart asymmetric effects on UBQLN2 phase separation

Shuttle protein UBQLN2 functions in protein quality control (PQC) by binding to proteasomal receptors and ubiquitinated substrates via its N‐terminal ubiquitin‐like (UBL) and C‐terminal ubiquitin‐associated (UBA) domains, respectively. Between these two folded domains are low‐complexity STI1‐I and STI1‐II regions, connected by disordered linkers. The STI1 regions bind other components, such as HSP70, that are important to the PQC functions of UBQLN2. We recently determined that the STI1‐II region enables UBQLN2 to undergo liquid–liquid phase separation (LLPS) to form liquid droplets in vitro and biomolecular condensates in cells. However, how the interplay between the folded (UBL/UBA) domains and the intrinsically disordered regions mediates phase separation is largely unknown. Using engineered domain deletion constructs, we found that removing the UBA domain inhibits UBQLN2 LLPS while removing the UBL domain enhances LLPS, suggesting that UBA and UBL domains contribute asymmetrically in modulating UBQLN2 LLPS. To explain these differential effects, we interrogated the interactions that involve the UBA and UBL domains across the entire UBQLN2 molecule using nuclear magnetic resonance spectroscopy. To our surprise, aside from well‐studied canonical UBL:UBA interactions, there also exist moderate interactions between the UBL and several disordered regions, including STI1‐I and residues 555–570, the latter of which is a known contributor to UBQLN2 LLPS. Our findings are essential for the understanding of both the molecular driving forces of UBQLN2 LLPS and the effects of ligand binding to UBL, UBA, or disordered regions on the phase behavior and physiological functions of UBQLN2.     

The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10

Proteins selected for degradation are labeled with multiple molecules of ubiquitin and are subsequently cleaved by the 26 S proteasome. A family of proteins containing at least one ubiquitin-associated (UBA) domain and one ubiquitin-like (UBL) domain have been shown to act as soluble ubiquitin receptors of the 26 S proteasome and introduce a new level of specificity into the degradation system. They bind ubiquitylated proteins via their UBA domains and the 26 S proteasome via their UBL domain and facilitate the contact between substrate and protease. NEDD8 ultimate buster-1 long (NUB1L) belongs to this class of proteins and contains one UBL and three UBA domains. We recently reported that NUB1L interacts with the ubiquitin-like modifier FAT10 and accelerates its degradation and that of its conjugates. Here we show that a deletion mutant of NUB1L lacking the UBL domain is still able to bind FAT10 but not the proteasome and no longer accelerates FAT10 degradation. A version of NUB1L lacking all three UBA domains, on the other hand, looses the ability to bind FAT10 but is still able to interact with the proteasome and accelerates the degradation of FAT10. The degradation of a FAT10 mutant containing only the C-terminal UBL domain is also still accelerated by NUB1L, even though the two proteins do not interact. In addition, we show that FAT10 and either one of its UBL domains alone can interact directly with the 26 S proteasome. We propose that NUB1L not only acts as a linker between the 26 S proteasome and ubiquitin-like proteins, but also as a facilitator of proteasomal degradation.